New reporting by CBS News highlights the actors fueling the spread of this medication, with more than 120 websites and dozens of medical clinics and spas across the country openly advertising or prescribing the drug
Swanda, R
Weight loss peptides (GLP-1 agonists) Examples : Semaglutide, Tirzepatide, Liraglutide Common side effects (mostly GI-related): Nausea : Frequency: 40-50% of users initially Severity: Mild to moderate Duration: Usually 1-3 weeks (improves with continued use) Management: Start low dose, increase gradually, eat smaller meals Constipation : Frequency: 20-30% of users Severity: Mild to moderate Management: Increase fiber, water, consider stool softener Diarrhea : Frequency: 15-20% of users Severity: Mild Duration: Usually temporary Management: Probiotics, reduce fatty foods Fatigue : Frequency: 20-30% initially Severity: Mild to moderate Duration: 2-4 weeks (improves as caloric deficit stabilizes) Management: Adequate protein, electrolytes, patience Reduced appetite (intended effect): Not a side effect - this is the mechanism Goal: 15-20% reduction in caloric intake Result: Weight loss Read our semaglutide vs tirzepatide comparison
Third-party 7x tested with Certificate of Analysis (COA) available
Ipamorelin is not FDA-approved as a prescription drug in the U.S., so product quality and labeling accuracy can be a major concern outside legitimate medical oversight
CRC remains a leading cause of cancer-related mortality worldwide, emphasizing the urgent need for effective treatment strategies (2022)
